Joglekar Savita, Nau Peter N, Mezhir James J
Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Division of Gastrointestinal and Minimally Invasive Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
J Surg Oncol. 2015 Oct;112(5):503-9. doi: 10.1002/jso.24025. Epub 2015 Aug 27.
Sarcopenia is the subclinical loss of skeletal muscle and strength and has been extensively studied in both the cancer and surgical literature. Specifically, sarcopenia has gained significant recognition as an important prognostic factor for both complications and survival in cancer patients. Herein, we review the current literature to date highlighting the specific impact of sarcopenia in patients undergoing oncologic procedures.
肌肉减少症是骨骼肌和力量的亚临床丧失,在癌症和外科文献中均已得到广泛研究。具体而言,肌肉减少症已被公认为癌症患者并发症和生存的重要预后因素。在此,我们回顾迄今为止的现有文献,重点介绍肌肉减少症对接受肿瘤手术患者的具体影响。